BioPharma Dive - Latest News

Lilly expands US manufacturing build-out with $50B target

The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry to reshore drug production.

Feb 26, 2025 - 15:37
 0
Lilly expands US manufacturing build-out with $50B target

The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry to reshore drug production.

Read More

Tags:

Previous Article

With plan to build 4 new plants, Eli Lilly doubles down on US drug manufacturing

Next Article

STAT+: Eli Lilly announces $27 billion investment in U.S. drug manufacturing sites

Related Posts

Cargo shelves cell therapy research and lays off almost all staff

Cargo shelves cell therapy research and lays off almost...

Mar 19, 2025  0

Arvinas gets positive breast cancer data, but finds differentiation a hard sell

Arvinas gets positive breast cancer data, but finds dif...

Mar 11, 2025  0

A new obesity biotech launches; Gilead plans to quickly advance once-yearly PrEP for HIV

A new obesity biotech launches; Gilead plans to quickly...

Mar 12, 2025  0